| Year |
Citation |
Score |
| 2016 |
Price JG, Idoyaga J, Merad M. Reply to: "Subverting misconceptions about radiation therapy". Nature Immunology. 17: 345-6. PMID 27002832 DOI: 10.1038/Ni.3376 |
0.613 |
|
| 2015 |
Price JG, Idoyaga J, Salmon H, Hogstad B, Bigarella CL, Ghaffari S, Leboeuf M, Merad M. CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation. Nature Immunology. 16: 1060-8. PMID 26343536 DOI: 10.1038/Ni.3270 |
0.671 |
|
| 2015 |
Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 212: 281. PMID 25646268 DOI: 10.1084/jem.2013097701202015c |
0.737 |
|
| 2014 |
Mielcarek M, Kirkorian AY, Hackman RC, Price J, Storer BE, Wood BL, Leboeuf M, Bogunovic M, Storb R, Inamoto Y, Flowers ME, Martin PJ, Collin M, Merad M. Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation. Transplantation. 98: 563-8. PMID 24717220 DOI: 10.1097/Tp.0000000000000097 |
0.739 |
|
| 2014 |
Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine. 211: 669-83. PMID 24638167 DOI: 10.1084/Jem.20130977 |
0.77 |
|
| 2014 |
Khosravi A, Yáñez A, Price JG, Chow A, Merad M, Goodridge HS, Mazmanian SK. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host & Microbe. 15: 374-81. PMID 24629343 DOI: 10.1016/J.Chom.2014.02.006 |
0.643 |
|
| 2014 |
Simko SJ, Berres M, Lim KP, Peters T, Price J, Lupo PJ, Hicks MJ, Shih A, Heym K, McClain KL, Merad M, Sarabia S, Lopez-Terrada D, Allen CE. Abstract B79: Detectable BRAF-V600E mutation in circulating peripheral blood of patients with Langerhans cell histiocytosis correlates with risk organ involvement and residual disease Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-B79 |
0.562 |
|
| 2013 |
Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, Becker CD, See P, Price J, Lucas D, Greter M, Mortha A, Boyer SW, Forsberg EC, Tanaka M, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 38: 792-804. PMID 23601688 DOI: 10.1016/J.Immuni.2013.04.004 |
0.694 |
|
| 2013 |
Phaik-Har Lim K, Peters TL, Berres M, Price J, Takizawa H, Lupo P, Hicks MJ, Shih A, Simko SJ, Heym KM, Bigley V, Collin MP, Manz MG, McClain K, Merad M, et al. Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia Blood. 122: 103-103. DOI: 10.1182/Blood.V122.21.103.103 |
0.705 |
|
| 2013 |
Price J, Hogstad B, Idoyaga J, LeBoeuf M, Bigarella C, Ghaffari S, Merad M. Unraveling the Mechanisms of Langerhans Cell Irradiation Resistance International Journal of Radiation Oncology*Biology*Physics. 87: S111-S112. DOI: 10.1016/J.Ijrobp.2013.06.288 |
0.674 |
|
| 2012 |
Greter M, Lelios I, Pelczar P, Hoeffel G, Price J, Leboeuf M, Kündig TM, Frei K, Ginhoux F, Merad M, Becher B. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity. 37: 1050-60. PMID 23177320 DOI: 10.1016/J.Immuni.2012.11.001 |
0.707 |
|
| 2012 |
Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, Pandey G, Leboeuf M, Elpek KG, Helft J, Hashimoto D, Chow A, Price J, Greter M, Bogunovic M, et al. Deciphering the transcriptional network of the dendritic cell lineage. Nature Immunology. 13: 888-99. PMID 22797772 DOI: 10.1038/Ni.2370 |
0.702 |
|
| 2011 |
Peters TL, Man TC, Price J, George R, Lim PH, Heym KM, Merad M, McClain KL, Allen CE. Frequent BRAF V600E Mutations Are Identified in CD207+ Cells in LCH Lesions, but BRAF Status does not Correlate with Clinical Presentation of Patients or Transcriptional Profiles of CD207+ Cells Blood. 118: 1372-1372. DOI: 10.1182/Blood.V118.21.1372.1372 |
0.572 |
|
| 2009 |
Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, Price J, Yin N, Bromberg J, Lira SA, Stanley ER, Nussenzweig M, Merad M. The origin and development of nonlymphoid tissue CD103+ DCs. The Journal of Experimental Medicine. 206: 3115-30. PMID 20008528 DOI: 10.1084/Jem.20091756 |
0.706 |
|
| Show low-probability matches. |